Royal Bank Of Canada Syros Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.69 - $1.21 $2,072 - $3,634	-3,004 Reduced 84.93%	533 $0
Q1 2022 May 16, 2022	SELL	$1.02 - $3.8 $9,141 - $34,055	-8,962 Reduced 71.7%	3,537 $4,000
Q4 2021 Feb 14, 2022	BUY	$3.26 - $4.66 $24,831 - $35,495	7,617 Added 156.02%	12,499 $40,000
Q3 2021 Nov 15, 2021	BUY	$4.08 - $5.66 $3,839 - $5,326	941 Added 23.88%	4,882 $22,000
Q2 2021 Aug 16, 2021	BUY	$5.01 - $7.48 $19,744 - $29,478	3,941 New	3,941 $21,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.